APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chronic Idiopathic Constipation (CIC) Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chronic Idiopathic Constipation (CIC) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173977960320 December 2025194 pages

Choose your research edition.

Industry ResearchChronic Idiopathic Constipation (CIC) Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Idiopathic Constipation (CIC) Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Chronic Idiopathic Constipation (CIC) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Idiopathic Constipation (CIC) Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Idiopathic Constipation (CIC) Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Chronic Idiopathic Constipation (CIC) Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chronic Idiopathic Constipation (CIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Idiopathic Constipation (CIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Idiopathic Constipation (CIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chronic Idiopathic Constipation (CIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Idiopathic Constipation (CIC) Drugs include Sanofi, Pfizer, GlaxoSmithKline, Bayer, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Salix Pharmaceuticals, Roche Holding and Progenics Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chronic Idiopathic Constipation (CIC) Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Idiopathic Constipation (CIC) Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Idiopathic Constipation (CIC) Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chronic Idiopathic Constipation (CIC) Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Chronic Idiopathic Constipation (CIC) Drugs Segment by Company

Sanofi

Pfizer

GlaxoSmithKline

Bayer

Synergy Pharmaceuticals

Sucampo Pharmaceuticals

Salix Pharmaceuticals

Roche Holding

Progenics Pharmaceuticals

Ironwood Pharmaceuticals

Ferring International Center

Chugai Pharmaceutical

Actavis

Chronic Idiopathic Constipation (CIC) Drugs Segment by Type

Lubiprostone

Linaclotide

Others

Chronic Idiopathic Constipation (CIC) Drugs Segment by Application

Ambulatory Surgical Centres

Hospitals & Clinics

Long Term Care Centres

Others

Chronic Idiopathic Constipation (CIC) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Idiopathic Constipation (CIC) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Idiopathic Constipation (CIC) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Idiopathic Constipation (CIC) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chronic Idiopathic Constipation (CIC) Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chronic Idiopathic Constipation (CIC) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chronic Idiopathic Constipation (CIC) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chronic Idiopathic Constipation (CIC) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chronic Idiopathic Constipation (CIC) Drugs Industry Trends Table 2. Chronic Idiopathic Constipation (CIC) Drugs Industry Drivers Table 3. Chronic Idiopathic Constipation (CIC) Drugs Industry Opportunities and Challenges Table 4. Chronic Idiopathic Constipation (CIC) Drugs Industry Restraints Table 5. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers Table 9. Global Chronic Idiopathic Constipation (CIC) Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Chronic Idiopathic Constipation (CIC) Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chronic Idiopathic Constipation (CIC) Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers, Product Type & Application Table 13. Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chronic Idiopathic Constipation (CIC) Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lubiprostone Table 17. Major Manufacturers of Linaclotide Table 18. Major Manufacturers of Others Table 19. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2021-2026) Table 23. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2027-2032) Table 24. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Ambulatory Surgical Centres Table 30. Major Manufacturers of Hospitals & Clinics Table 31. Major Manufacturers of Long Term Care Centres Table 32. Major Manufacturers of Others Table 33. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 35. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2027-2032) & (K Units) Table 36. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2021-2026) Table 37. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2027-2032) Table 38. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2026) & (K Units) Table 40. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2027-2032) & (K Units) Table 41. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2021-2026) Table 46. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 50. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2027-2032) & (K Units) Table 51. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 53. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2027-2032) Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 69. Sanofi Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 74. Pfizer Recent Development Table 75. GlaxoSmithKline Company Information Table 76. GlaxoSmithKline Business Overview Table 77. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 79. GlaxoSmithKline Recent Development Table 80. Bayer Company Information Table 81. Bayer Business Overview Table 82. Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bayer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 84. Bayer Recent Development Table 85. Synergy Pharmaceuticals Company Information Table 86. Synergy Pharmaceuticals Business Overview Table 87. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 89. Synergy Pharmaceuticals Recent Development Table 90. Sucampo Pharmaceuticals Company Information Table 91. Sucampo Pharmaceuticals Business Overview Table 92. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 94. Sucampo Pharmaceuticals Recent Development Table 95. Salix Pharmaceuticals Company Information Table 96. Salix Pharmaceuticals Business Overview Table 97. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 99. Salix Pharmaceuticals Recent Development Table 100. Roche Holding Company Information Table 101. Roche Holding Business Overview Table 102. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 104. Roche Holding Recent Development Table 105. Progenics Pharmaceuticals Company Information Table 106. Progenics Pharmaceuticals Business Overview Table 107. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 109. Progenics Pharmaceuticals Recent Development Table 110. Ironwood Pharmaceuticals Company Information Table 111. Ironwood Pharmaceuticals Business Overview Table 112. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 114. Ironwood Pharmaceuticals Recent Development Table 115. Ferring International Center Company Information Table 116. Ferring International Center Business Overview Table 117. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 119. Ferring International Center Recent Development Table 120. Chugai Pharmaceutical Company Information Table 121. Chugai Pharmaceutical Business Overview Table 122. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 124. Chugai Pharmaceutical Recent Development Table 125. Actavis Company Information Table 126. Actavis Business Overview Table 127. Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Actavis Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 129. Actavis Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Chronic Idiopathic Constipation (CIC) Drugs Distributors List Table 133. Chronic Idiopathic Constipation (CIC) Drugs Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Chronic Idiopathic Constipation (CIC) Drugs Product Image Figure 2. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (2021-2032) & (K Units) Figure 5. Global Chronic Idiopathic Constipation (CIC) Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Chronic Idiopathic Constipation (CIC) Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lubiprostone Image Figure 9. Linaclotide Image Figure 10. Others Image Figure 11. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2021-2032) Figure 17. Ambulatory Surgical Centres Image Figure 18. Hospitals & Clinics Image Figure 19. Long Term Care Centres Image Figure 20. Others Image Figure 21. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2021-2032) Figure 41. China Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Chronic Idiopathic Constipation (CIC) Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Chronic Idiopathic Constipation (CIC) Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Lubiprostone
  • Linaclotide
  • Others
Applications
  • Ambulatory Surgical Centres
  • Hospitals & Clinics
  • Long Term Care Centres
  • Others
Companies covered
  • Sanofi
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Synergy Pharmaceuticals
  • Sucampo Pharmaceuticals
  • Salix Pharmaceuticals
  • Roche Holding
  • Progenics Pharmaceuticals
  • Ironwood Pharmaceuticals
  • Ferring International Center
  • Chugai Pharmaceutical
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chronic Idiopathic Constipation (CIC) Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Dynamics
  1. 2.1 Chronic Idiopathic Constipation (CIC) Drugs Industry Trends
  2. 2.2 Chronic Idiopathic Constipation (CIC) Drugs Industry Drivers
  3. 2.3 Chronic Idiopathic Constipation (CIC) Drugs Industry Opportunities and Challenges
  4. 2.4 Chronic Idiopathic Constipation (CIC) Drugs Industry Restraints
3 Chronic Idiopathic Constipation (CIC) Drugs Market by Manufacturers
  1. 3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chronic Idiopathic Constipation (CIC) Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chronic Idiopathic Constipation (CIC) Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chronic Idiopathic Constipation (CIC) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chronic Idiopathic Constipation (CIC) Drugs Tier 1, Tier 2, and Tier 3
4 Chronic Idiopathic Constipation (CIC) Drugs Market by Type
  1. 4.1 Chronic Idiopathic Constipation (CIC) Drugs Type Introduction
  2. 4.1.1 Lubiprostone
  3. 4.1.2 Linaclotide
  4. 4.1.3 Others
  5. 4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type
  6. 4.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type
  10. 4.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2021-2032)
5 Chronic Idiopathic Constipation (CIC) Drugs Market by Application
  1. 5.1 Chronic Idiopathic Constipation (CIC) Drugs Application Introduction
  2. 5.1.1 Ambulatory Surgical Centres
  3. 5.1.2 Hospitals & Clinics
  4. 5.1.3 Long Term Care Centres
  5. 5.1.4 Others
  6. 5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application
  7. 5.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application
  11. 5.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2021-2032)
6 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region
  1. 6.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region
  1. 7.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region
  2. 7.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032)
  8. 7.2.2 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Synergy Pharmaceuticals
  26. 8.5.1 Synergy Pharmaceuticals Company Information
  27. 8.5.2 Synergy Pharmaceuticals Business Overview
  28. 8.5.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  30. 8.5.5 Synergy Pharmaceuticals Recent Developments
  31. 8.6 Sucampo Pharmaceuticals
  32. 8.6.1 Sucampo Pharmaceuticals Company Information
  33. 8.6.2 Sucampo Pharmaceuticals Business Overview
  34. 8.6.3 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  36. 8.6.5 Sucampo Pharmaceuticals Recent Developments
  37. 8.7 Salix Pharmaceuticals
  38. 8.7.1 Salix Pharmaceuticals Company Information
  39. 8.7.2 Salix Pharmaceuticals Business Overview
  40. 8.7.3 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  42. 8.7.5 Salix Pharmaceuticals Recent Developments
  43. 8.8 Roche Holding
  44. 8.8.1 Roche Holding Company Information
  45. 8.8.2 Roche Holding Business Overview
  46. 8.8.3 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  48. 8.8.5 Roche Holding Recent Developments
  49. 8.9 Progenics Pharmaceuticals
  50. 8.9.1 Progenics Pharmaceuticals Company Information
  51. 8.9.2 Progenics Pharmaceuticals Business Overview
  52. 8.9.3 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  54. 8.9.5 Progenics Pharmaceuticals Recent Developments
  55. 8.10 Ironwood Pharmaceuticals
  56. 8.10.1 Ironwood Pharmaceuticals Company Information
  57. 8.10.2 Ironwood Pharmaceuticals Business Overview
  58. 8.10.3 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  60. 8.10.5 Ironwood Pharmaceuticals Recent Developments
  61. 8.11 Ferring International Center
  62. 8.11.1 Ferring International Center Company Information
  63. 8.11.2 Ferring International Center Business Overview
  64. 8.11.3 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  66. 8.11.5 Ferring International Center Recent Developments
  67. 8.12 Chugai Pharmaceutical
  68. 8.12.1 Chugai Pharmaceutical Company Information
  69. 8.12.2 Chugai Pharmaceutical Business Overview
  70. 8.12.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  72. 8.12.5 Chugai Pharmaceutical Recent Developments
  73. 8.13 Actavis
  74. 8.13.1 Actavis Company Information
  75. 8.13.2 Actavis Business Overview
  76. 8.13.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  78. 8.13.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chronic Idiopathic Constipation (CIC) Drugs Value Chain Analysis
  2. 9.1.1 Chronic Idiopathic Constipation (CIC) Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chronic Idiopathic Constipation (CIC) Drugs Production Mode & Process
  6. 9.2 Chronic Idiopathic Constipation (CIC) Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chronic Idiopathic Constipation (CIC) Drugs Distributors
  9. 9.2.3 Chronic Idiopathic Constipation (CIC) Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst